### ü§ñ SpectruthAI DAO - AMA Announcement

This article announces a live AMA with James Holz Esq. and Koko of Web3, focusing on the transformation of mental healthcare using AI.  The event will cover SpectruthAI's revolutionary AI and its applications.

Key Points:

‚Ä¢ Live AMA with experts in mental health and AI.

‚Ä¢ Discussion on the transformative potential of AI in mental healthcare.

‚Ä¢ Opportunity to ask questions and engage with the SpectruthAI community.


üîó Resources:

‚Ä¢ [SpectruthAI](https://x.com/SpectruthAI) - AI for mental health

‚Ä¢ [James Holz Esq.](https://x.com/JamesHolzEsq) - Legal expert

‚Ä¢ [Koko of Web3](https://x.com/kokoofweb3) - Web3 expert

![Image](https://pbs.twimg.com/media/GzG8e0hW4AAQ8W8?format=jpg&name=small)


---
### üöÄ SpectruthAI DAO - Updates and BIO AIAgent Launch

This article summarizes recent updates from the SpectruthAI DAO, including progress on their groundbreaking AI, the launch of a new BIO AIAgent, ongoing research projects, collaborations, and an upcoming token launch.  An AMA is also announced.

Key Points:

‚Ä¢ Groundbreaking progress on AI development.

‚Ä¢ Launch of a new BIO AIAgent.

‚Ä¢ Ongoing research projects and fruitful collaborations.

‚Ä¢ Upcoming token launch.


üîó Resources:

‚Ä¢ [SpectruthAI](https://x.com/SpectruthAI) - AI development updates

![Image](https://pbs.twimg.com/media/GzG5hyyWUAAk_Rq?format=jpg&name=small)


---
### üí° DeSci Tokens - Market Cap Predictions

This article lists DeSci tokens predicted to reach a $1B market cap, highlighting current top contenders and other strong possibilities.  Market cap values are provided for the top runners.

Key Points:

‚Ä¢ $BIO is a leading contender with a current market cap of $565M.

‚Ä¢ Several other tokens show strong potential for significant growth.

‚Ä¢ The list includes a variety of projects in the DeSci space.


---
### ü§ñ OpenMed NER Paper - Open-Source Healthcare AI

This article discusses the release of the OpenMed NER paper on Hugging Face, which validates the performance of over 380 state-of-the-art open-source models for healthcare AI. The research demonstrates the effectiveness of open-source alternatives to expensive closed-source solutions.

Key Points:

‚Ä¢ OpenMed NER paper validates 380+ open-source healthcare AI models.

‚Ä¢ The research demonstrates that open-source models can outperform expensive, closed-source alternatives.

‚Ä¢ The paper details the methodology and reasoning behind the project.


üîó Resources:

‚Ä¢ [OpenMed AI](https://x.com/OpenMed_AI) - Open-source healthcare AI

‚Ä¢ [Hugging Face](https://x.com/huggingface) - Platform for the paper

![Image](https://pbs.twimg.com/media/GxlsWhTXIAAK-wN?format=jpg&name=small)


---
### üí° Signos - Personalized Weight Management

This article promotes Signos, a personalized weight management system, highlighting its benefits for sustainable weight management, energy levels, food enjoyment, and sleep quality.

Key Points:

‚Ä¢ Sustainable weight management approach.

‚Ä¢ Increased energy levels.

‚Ä¢ Guilt-free food enjoyment.

‚Ä¢ Improved sleep quality.


üîó Resources:

‚Ä¢ [Signos Health](https://x.com/SignosHealth) - Personalized weight management

![Image](https://pbs.twimg.com/media/GzFFcTPXgAAY3bQ?format=jpg&name=small)


---
### ü§ñ Ibex AI - Prostate Cancer Diagnosis

This article highlights a publication by CorePlus showcasing over three years of real-world data demonstrating the effectiveness of Ibex's AI for prostate cancer diagnosis. The algorithm achieved a high negative predictive value (NPV).

Key Points:

‚Ä¢ Real-world data shows effectiveness of Ibex's AI.

‚Ä¢ High NPV achieved in prostate cancer diagnosis.

‚Ä¢ Demonstrates the successful application of AI in healthcare.


üîó Resources:

‚Ä¢ [IbexMedAx](https://x.com/IbexMedAx) - AI for prostate cancer diagnosis

![Image](https://pbs.twimg.com/media/Gy-KdEtXMAABMWE?format=jpg&name=small)
![Image](https://pbs.twimg.com/media/Gy-KdbuWEAAbKrG?format=jpg&name=small)


---
### ü§ñ OpenAI and Retro Biosciences - Drug Discovery

This article discusses OpenAI's collaboration with Retro Biosciences, focusing on the development of improved variants of Yamanaka proteins using custom AI models.  A publication detailing the breakthrough is mentioned.

Key Points:

‚Ä¢ AI accelerates science and drug discovery.

‚Ä¢ Improved variants of Yamanaka proteins developed using custom AI models.

‚Ä¢ Publication detailing the breakthrough is available.


üîó Resources:

‚Ä¢ [OpenAI](https://x.com/OpenAI) - AI for science and drug discovery

‚Ä¢ [Retro Biosciences](https://x.com/RetroBiosciences) - Biotech company

![Image](https://pbs.twimg.com/media/Gy93mZPboAEztVP?format=jpg&name=small)


---
### ü§ñ AI Capabilities - A Humorous Perspective

This article humorously lists various capabilities people expect from AI, highlighting the progression and future potential of AI technology.

Key Points:

‚Ä¢ A lighthearted look at AI capabilities and expectations.


![Image](https://pbs.twimg.com/media/Gyz2WavXIAAhWXr?format=jpg&name=small)


---
### ‚ú® Superpower Health - All-in-One Health Membership

This article promotes Superpower Health's all-in-one health membership, which includes comprehensive lab tests, personalized health scores, data aggregation, and action plans for $199.

Key Points:

‚Ä¢ Comprehensive lab testing.

‚Ä¢ Personalized health scores and biological age assessment.

‚Ä¢ Centralized health data management.

‚Ä¢ Personalized action plans.


---
### ü§ñ Camidestrant SERENA-1 Results - Oncology Study

This article presents results from the Camidestrant SERENA-1 clinical trial, detailing objective response rates (ORR) and median progression-free survival (mPFS) for different treatment combinations and ESR1 statuses.

Key Points:

‚Ä¢ Data on Camidestrant combined with CDK4/6 inhibitors.

‚Ä¢ ORR and mPFS values are provided for various groups.

‚Ä¢ Results are broken down by CDK4/6 inhibitor used and ESR1 status.



---


---

### ‚≠êÔ∏è Support

If you liked reading this report, please star ‚≠êÔ∏è this repository and follow me on [Github](https://github.com/Drix10), [ùïè (previously known as Twitter)](https://x.com/DRIX_10_) to help others discover these resources and regular updates.

---